Fridman; Wolf-Herman

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fridman; Wolf-Herman.The latest application filed is for "in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method".

Company Profile

1.12.11

Fridman; Wolf-Herman - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
In Vitro Method for the Prognosis of Progression of a Cancer and of the Outcome in a Patient and Means for Performing Said Method App 20220308063 - Galon; Jerome ; et al.	2022-09-29
In vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method Grant 11,300,569 - Galon , et al. April 12, 2	2022-04-12
In Vitro Method For The Prognosis Of Progression Of A Cancer And Of The Outcome In A Patient And Means For Performing Said Metho App 20190178892 - Galon; Jerome ; et al.	2019-06-13
In vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method Grant 10,191,059 - Galon , et al. Ja	2019-01-29
In Vitro Method For The Prognosis Of Progression Of A Cancer And Of The Outcome In A Patient And Means For Performing Said Method App 20150268245 - Galon; Jerome ; et al.	2015-09-24
In Vitro Method For The Prognosis Of Progression Of A Cancer And Of The Outcome In A Patient And Means For Performing Said Method App 20140057257 - Galon; Jerome ; et al.	2014-02-27
Vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method Grant 8,481,271 - Galon , et al. July 9, 2	2013-07-09
Inhibitors Of Interleukin-1 Beta Converting Enzyme App 20120165319 - Batchelor; Mark James ; et al.	2012-06-28
Inhibitors of interleukin-1.beta. converting enzyme Grant 8,119,631 - Batchelor , et al. February 21, 2	2012-02-21
Inhibitors Of Interleukin-1 Beta Converting Enzyme App 20110178069 - Batchelor; Mark James ; et al.	2011-07-21
Preparation of human, humanized or chimaeric antibodies or polypeptides having different binding profiles to Fcgamma receptors Grant 7,790,399 - Bourel , et al. September 7, 2	2010-09-07
Inhibitors of interleukin-1.beta. converting enzyme Grant 7,790,713 - Batchelor , et al. September 7, 2	2010-09-07
Vitro Method for the Prognosis of Progression of a Cancer and of the Outcome in a Patient and Means for Performing Said Method App 20090215053 - Galon; Jerome ; et al.	2009-08-27
Inhibitors of interleukin-1beta converting enzyme App 20080039449 - Batchelor; Mark James ; et al.	2008-02-14
Therapeutic products with enhance ability to immunomodulate cell functions App 20070135621 - Bourel; Dominique ; et al.	2007-06-14
Inhibitors of interleukin-1beta converting enzyme App 20050143436 - Batchelor, Mark James ; et al.	2005-06-30
Inhibitors of interleukin-1beta converting enzyme App 20030225269 - Batchelor, Mark James ; et al.	2003-12-04
Inhibitors of interleukin-1.beta. converting enzyme Grant 6,423,840 - Batchelor , et al. July 23, 2	2002-07-23
Inhibitors of Interleukin-1.beta. converting enzyme Grant 6,258,948 - Batchelor , et al. July 10, 2	2001-07-10
Inhibitors of interleukin-1.beta. Converting enzyme inhibitors Grant 6,204,261 - Batchelor , et al. March 20, 2	2001-03-20
Inhibitors of interleukin-1.beta. converting enzyme Grant 6,008,217 - Batchelor , et al. December 28, 1	1999-12-28
Inhibitors of interleukin-1.beta. converting enzyme Grant 5,874,424 - Batchelor , et al. February 23, 1	1999-02-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.